Joerg, V., Scheiner, B., Bengsch, B., Pinato, D.J., Schulze, K. und Felden, J. von (2023) Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study [cd]. Freiburg: Universität. doi:10.1097/hc9.0000000000000302.
Chicago Manual of Style 17th edition (full note)Joerg, Vincent, Bernhard Scheiner, Bertram Bengsch, David James Pinato, Kornelius Schulze, und Johann von Felden. Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study. Cd. Freiburg: Universität, [2023?], Freiburg: Universität, [2023?]. https://doi.org/10.1097/hc9.0000000000000302.
American Psychological Association 7th editionJoerg, V., Scheiner, B., Bengsch, B., Pinato, D. J., Schulze, K., & Felden, J. von. (ca. 2023). Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study [Cd]. Universität. https://doi.org/10.1097/hc9.0000000000000302
Modern Language Association 9th editionJoerg, V., B. Scheiner, B. Bengsch, D. J. Pinato, K. Schulze, und J. von Felden. Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study. cd, Universität, 2023, https://doi.org/10.1097/hc9.0000000000000302.
ISO-690 (author-date, Deutsch)JOERG, Vincent, Bernhard SCHEINER, Bertram BENGSCH, David James PINATO, Kornelius SCHULZE und Johann von FELDEN, 2023. Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study. Freiburg: Universität